![Matthew Moyle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Moyle
Nessuna posizione attualmente
Profilo
Matthew Moyle worked as the Head of Expression Profiling Department at Amgen, Inc. from 1995 to 2001.
He then worked as a Scientist at Genentech, Inc. from 2001 to 2005.
After that, he worked as a Group Leader at Corvas International, Inc. He was the Vice President of Biotherapeutics at Boehringer Ingelheim GmbH from 2010 to 2015.
He also worked as the Vice President of Research at Tanox, Inc. and as the Chief Scientific Officer and Senior Vice President at Theraclone Sciences, Inc. from 2007 to 2010.
In 2016 and 2017, he was the Chief Scientific Officer at AnaptysBio, Inc. He also worked as the Vice President of Biotherapeutics at Boehringer Ingelheim Pharmaceuticals, Inc. Dr. Moyle received his undergraduate and doctorate degrees from the University of Toronto.
Precedenti posizioni note di Matthew Moyle
| Società | Posizione | Fine |
|---|---|---|
| ANAPTYSBIO, INC. | Direttore Tecnico/Scientifico/R&S | 21/07/2017 |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Corporate Officer/Principal | 01/08/2015 |
Theraclone Sciences, Inc.
 Theraclone Sciences, Inc. BiotechnologyHealth Technology Develops therapeutic antibodies for the treatment of infectious disease and inflammation | Direttore Tecnico/Scientifico/R&S | 01/10/2010 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Direttore Tecnico/Scientifico/R&S | 01/08/2005 |
Tanox, Inc.
 Tanox, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody and pharmaceutical solutions used for the treatment of allergic diseases | Direttore Tecnico/Scientifico/R&S | 27/04/2005 |
Formazione di Matthew Moyle
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
87
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Corvas International, Inc.
 Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases | Health Technology |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Health Technology |
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody and pharmaceutical solutions used for the treatment of allergic diseases | Health Technology |
Theraclone Sciences, Inc.
Theraclone Sciences, Inc. BiotechnologyHealth Technology Develops therapeutic antibodies for the treatment of infectious disease and inflammation | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
